Transitioning from Semaglutide GLP-1 to tirzepatide is a carefully managed process
Long-term impacts may include chronic digestive dysfunction, difficulty eating or absorbing nutrients, and an increased risk of future infections
Nutrient deficiency can lead to various health problems, including a weakened immune system, skin issues, digestive problems, impaired bone growth, and neurological disorders
Emphasizing the challenges faced by patients from remote areas, the prime minister highlighted the importance of early screening, public awareness, and timely treatment
In phase 3 clinical trials, tirzepatide improved liver fibrosis in individuals with metabolic dysfunction-associated steatohepatitis (MASH) 4 , and outperformed semaglutide in the management of obesity 1 and type 2 diabetes 2
albiglutide, dulaglutide, semaglutide, lixisenatide 0.5-1.69%